In the past week, VANI stock has gone down by -8.54%, with a monthly decline of -16.67% and a quarterly plunge of -11.42%. The volatility ratio for the week is 4.44%, and the volatility levels for the last 30 days are 4.69% for Vivani Medical Inc The simple moving average for the past 20 days is -9.27% for VANI’s stock, with a -22.06% simple moving average for the past 200 days.
Is It Worth Investing in Vivani Medical Inc (NASDAQ: VANI) Right Now?
VANI has 36-month beta value of 3.22. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for VANI is 30.19M, and currently, short sellers hold a 2.87% ratio of that float. The average trading volume of VANI on September 27, 2024 was 86.17K shares.
VANI) stock’s latest price update
The stock of Vivani Medical Inc (NASDAQ: VANI) has decreased by -4.66 when compared to last closing price of 1.18.Despite this, the company has seen a loss of -8.54% in its stock price over the last five trading days. businesswire.com reported 2024-09-26 that ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, biopharmaceutical company developing novel, ultra long-acting drug implants, today announced that the Bellberry Human Research Ethics Committee (“HREC”) has approved and the Therapeutic Goods Administration (“TGA”) in Australia has formally acknowledged a first in human clinical trial of the Company’s miniature, subdermal GLP-1 (exenatide) implant in obese and overweight subjects. T.
VANI Trading at -10.14% from the 50-Day Moving Average
After a stumble in the market that brought VANI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.58% of loss for the given period.
Volatility was left at 4.69%, however, over the last 30 days, the volatility rate increased by 4.44%, as shares sank -14.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.41% lower at present.
During the last 5 trading sessions, VANI fell by -8.54%, which changed the moving average for the period of 200-days by +20.18% in comparison to the 20-day moving average, which settled at $1.2303. In addition, Vivani Medical Inc saw 10.29% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VANI starting from Dwyer Donald, who purchase 5,000 shares at the price of $1.24 back on Jul 30 ’24. After this action, Dwyer Donald now owns 43,500 shares of Vivani Medical Inc, valued at $6,200 using the latest closing price.
Dwyer Donald, the Chief Business Officer of Vivani Medical Inc, purchase 4,000 shares at $1.23 during a trade that took place back on Jul 31 ’24, which means that Dwyer Donald is holding 47,500 shares at $4,920 based on the most recent closing price.
Stock Fundamentals for VANI
Current profitability levels for the company are sitting at:
- -48.78 for the present operating margin
- 0.29 for the gross margin
The net margin for Vivani Medical Inc stands at -46.72. The total capital return value is set at -0.6. Equity return is now at value -86.10, with -44.89 for asset returns.
Based on Vivani Medical Inc (VANI), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at -1.02. The debt to equity ratio resting at 0.84. The interest coverage ratio of the stock is -89.29.
Currently, EBITDA for the company is -26.61 million with net debt to EBITDA at 0.2. When we switch over and look at the enterprise to sales, we see a ratio of 110.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.55.
Conclusion
To put it simply, Vivani Medical Inc (VANI) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
